External Source

Dr Garon On Considerations For Perioperative Immunotherapy Use In Lung Cancer

2024 2:13
Synopsis
Edward B. Garon, MD, MS, professor of medicine, Department of Medicine, Division of Hematology/Oncology, David Geffen ...

You Might Also Like

Dr. Garon on Potential for Immunotherapy in EGFR+ NSCLC 0:56
Dr. Garon On Potential For Immunotherapy In Egfr+ Nsclc
2019
Dr. Garon on Concerns for Immunotherapy Combinations in Lung Cancer 2:30
Dr. Garon On Concerns For Immunotherapy Combinations In Lung...
2016
Dr. Garon Discusses Immunotherapy as Salvage Treatment for Advanced Lung Cancer 1:14
Dr. Garon Discusses Immunotherapy As Salvage Treatment For A...
2017
Dr. Garon on the Expanding Treatment Landscape in Lung Cancer 1:04
Dr. Garon On The Expanding Treatment Landscape In Lung Cance...
2020
Advances in perioperative immunotherapy in lung cancer 2:44
Advances In Perioperative Immunotherapy In Lung Cancer
2021
How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans in Resectable NSCLC 49:11
How To Integrate Perioperative Immunotherapy Into Multimodal...
2022
Dr. Garon on Antiangiogenic Agents in Lung Cancer 1:25
Dr. Garon On Antiangiogenic Agents In Lung Cancer
2017
A Discussion on Immune Checkpoint Inhibitors in Lung Cancer 2:51
A Discussion On Immune Checkpoint Inhibitors In Lung Cancer
2014
Dr. Cascone on Remaining Challenges With Perioperative Immunotherapy in NSCLC 1:12
Dr. Cascone On Remaining Challenges With Perioperative Immun...
2019
Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC 39:06
Unleashing The Potential Of Perioperative Immunotherapy In R...
2023
ASCO 2025: Dr. Hafez’s 25% pCR Lung Cancer Immunotherapy Breakthrough 10:38
Asco 2025: Dr. Hafez’s 25% Pcr Lung Cancer Immunotherapy B...
2025
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.